ARID1A and endometrioid adenocarcinoma: Most frequent somatic mutations involved TP53 (N = 15, all HGSC), followed by ARID1A (N = 2, all clear cell cancer), and PIK3CA (N = 2, one clear cell and one endometrioid carcinoma).